Regensburg, April 30, 2008 - GENEART AG, the global leader in gene synthesis and specialist in the field of Synthetic Biology, continued its strong growth of 2007 into the first quarter of 2008, thus confirming its positive outlook for 2008. According to preliminary results for the first quarter 2008, net sales increased to EUR 3.9M. This corresponds to an increase of more than 60 % compared to the prior year (2007: EUR 2.4M). According to preliminary IFRS results, the operating result (EBIT) in the first quarter of 2008 is EUR 0.5M (2007: EUR 0.4M). For the first time, the GENEART Group reports current year results for the first quarter 2008 according to International Financial Reporting Standards (IFRS). Due to this change, final results for the first quarter 2008 will be published on May 29, 2008, as scheduled.
